Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
Transplantation|December 14, 2006
The association between angiotensin converting enzyme inhibitor or angiotensin receptor blocker use during postischemic acute transplant failure and renal allograft survivalGeorg Heinze, Sean Collins, Michael A Benedict, et al.
Wiener Klinische Wochenschrift|November 20, 2013
Long-term follow-up after allogeneic stem cell transplantation in patients with myelodysplastic syndromes or secondary acute myeloid leukemia: a single center experienceAlexandra Boehm, Wolfgang R Sperr, Peter Kalhs, et al.
Transplantation|April 25, 2007
Gene-expression profiles and age of donor kidney biopsies obtained before transplantation distinguish medium term graft functionAlexander Kainz, Paul Perco, Bernd Mayer, et al.
Plos One|August 6, 2014
Molecular pathogenesis of post-transplant acute kidney injury: assessment of whole-genome mRNA and miRNA profilesJulia Wilflingseder, Judith Sunzenauer, Eva Toronyi, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 30, 2021
Waiting Time for Second Kidney Transplantation and MortalityAlexander Kainz, Michael Kammer, Roman Reindl-Schwaighofer, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|May 13, 2021
Renal allograft DARCness in subclinical acute and chronic active ABMRJohannes Kläger, Farsad Eskandary, Georg A Böhmig, et al.
Kidney International|December 1, 2005
Transcriptional response in the unaffected kidney after contralateral hydronephrosis or nephrectomyPeter Hauser, Alexander Kainz, Paul Perco, et al.
Kidney International|July 4, 2025
A systematic literature review and meta-analysis evaluated modifiable risk factors for the development of BK polyoma virus-associated complicationsMichael Eder, Alexander Kainz, Haris Omic, et al.
Plos One|August 4, 2012
Sirolimus induced phosphaturia is not caused by inhibition of renal apical sodium phosphate cotransportersMaria Haller, Stefan Amatschek, Julia Wilflingseder, et al.
Current Medical Research and Opinion|September 21, 2010
Impact of CYP2D6*4 genotype on progression free survival in tamoxifen breast cancer treatmentJulia Carolin Stingl, Sumit Parmar, Ariana Huber-Wechselberger, et al.
Pageof 9